Loading company…
Riskpilot
← Back to search
Sign in
Get full access
JKS AS
AS
Active
Org 926522930
Slemdalsveien 1, 0369 Oslo
Medical specialists activities · NACE 8622
Est. 2021
1 employees
Watchlist
Share
Download PDF
Full Risika report
Overview
Financials
People & ownership
Related companies
Revenue 2024
NOK 5,9M
+4% vs 2023
EBITDA margin
58.0%
-3% vs 2023
Equity ratio
89.8%
Financial strength
Net profit 2024
NOK 3,4M
+24% vs 2023
EBITDA — year on year
NOK millions
5M
4M
3M
1M
0M
2M
2021
3M
+50%
2022
4M
+33%
2023
3M
-25%
2024
Key figures
Annual report 2024
Revenue
NOK 5,9M
+4%
EBITDA
NOK 3,4M
-3%
Net profit
NOK 3,4M
+24%
Total assets
NOK 8,1M
+19%
Equity
NOK 7,3M
+23%
Employees
1
—
Company information
Legal name
JKS AS
Org number
926522930
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
4. februar 2021
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene. Daglig leder alene.
Company purpose
Spesialistlegetjenester og det som naturlig faller inn under dette.
Contact
Address
Slemdalsveien 1, 0369 Oslo
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Medical specialists activities
Companies in Oslo
All Norway companies
Revenue
NOK millions
0M
2M
3M
5M
7M
5M
2021
5M
2022
6M
2023
6M
2024
EBITDA
NOK millions
0M
1M
2M
3M
5M
2M
2021
3M
2022
4M
2023
3M
2024
Income statement
NOK thousands
Item
2021
2022
2023
2024
Revenue
4 667
5 419
5 712
5 935
Staff expenses
−1 521
−887
−901
−897
EBITDA
1 788
3 338
3 532
3 441
Depreciation & amort.
−467
−521
−176
−521
EBIT
1 322
2 816
3 356
2 920
Net financials
0
0
119
1 115
Profit before tax
1 322
2 816
3 475
4 035
Tax
289
630
763
678
Net profit
1 032
2 186
2 712
3 357
Balance sheet
NOK thousands
Item
2021
2022
2023
2024
Total assets
4 876
4 085
6 855
8 140
Equity
1 051
3 237
5 949
7 306
Long-term debt
3 336
0
24
0
Short-term debt
489
848
882
834
Total debt
3 825
848
906
834
Financial ratios
5-year trend
EBITDA margin
58.0%
This company
15.8%
Market median
+267% vs market
2021
2024
Equity ratio
89.8%
This company
38.2%
Market median
+135% vs market
2021
2024
Return on equity
46.0%
This company
18.4%
Market median
+150% vs market
2021
2024
Net profit margin
56.6%
This company
8.1%
Market median
+599% vs market
2021
2024
Asset turnover
0.73×
This company
1.12×
Market median
-35% vs market
2021
2024
Debt / equity
0.11×
This company
0.62×
Market median
+82% vs market
2021
2024
Annual reports & filings
Annual report 2024
Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (1)
JK
Jon Klokk Slettedal
Chairman
2021
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
JKS AS
(this company)
BLIKK ØYEKLINIKK AS
JKS NORGE AS
Board network connections
Board members of JKS AS also hold positions in
0
other companies.
Person
Role here
Other companies
Jon Klokk Slettedal
Chairman
0 companies